Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-12-17

FDA Approved: EDLUAR — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

The FDA approved a supplemental NDA for EDLUAR (zolpidem tartrate) filed by Viatris Specialty LLC. The approval reflects changes approved as part of the supplem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EDLUAR (ZOLPIDEM TARTRATE)

Snippet

SUPPL AP for EDLUAR (ZOLPIDEM TARTRATE)